Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-20-057070

Director sold 7,500 shares at an average $136.36 ($1,022,665)

From the SEC's structured data for this filing

Trades in this filing

STUELPNAGEL JOHN R · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-02 Sale : show line 1 in the form −2,328 $135.62 $315,723 516,163 D
2020-11-02 Sale : show line 2 in the form −3,900 $136.23 $531,296 512,263 D
2020-11-02 Sale : show line 3 in the form −772 $137.47 $106,129 511,491 D
2020-11-02 Sale : show line 4 in the form −500 $139.03 $69,517 510,991 D
Open-market sales · 7,500 sh · avg $136.36 · $1,022,665
Loading xslF345X03/doc4.xml…